✦ LIBER ✦

Haematopoietic growth factor therapy `may be an attractive and simple alternative'

Book ID: 120867797
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2000
Weight: 151 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200012600-00023

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Topical photodynamic therapy with methyl

Topical photodynamic therapy with methyl aminolevulinate may be an alternative therapeutic option for the recalcitrant Malassezia folliculitis

✍ Jin Woong Lee; Hye In Lee; Myeung Nam Kim; Beom Joon Kim; Young-Jin Chun; Dongha 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Transforming Growth Factor α May Be a Ph

Transforming Growth Factor α May Be a Physiological Regulator of Liver Regeneration by means of an Autocrine Mechanism

✍ Janet E. Mead and Nelson Fausto 📂 Article 📅 1989 🏛 National Academy of Sciences 🌐 English ⚖ 914 KB

Expression of milk fat globule epidermal

Expression of milk fat globule epidermal growth factor-VIII may be an indicator of poor prognosis in malignant melanoma

✍ J. Oba; Y. Moroi; T. Nakahara; T. Abe; A. Hagihara; M. Furue 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB

B cell depletion may be more effective t

B cell depletion may be more effective than switching to an alternative anti–tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti–tumor necrosis factor agents

✍ Axel Finckh; Adrian Ciurea; Laure Brulhart; Diego Kyburz; Burkhard Möller; Silvi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views

## Abstract ## Objective Patients with rheumatoid arthritis (RA) in whom the response to anti–tumor necrosis factor (anti‐TNF) therapy is inadequate have several therapeutic options, such as switching to an alternative anti‐TNF agent or initiating B cell–depleting therapy with rituximab (RTX). Alt